Literature DB >> 6171518

Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.

K Oguma, B Syuto, T Agui, H Iida, S Kubo.   

Abstract

Five Clostridium botulinum strains were used in the present work, two of type C, C-Stockholm (C-ST) and C-CB19, and three of type D, D-South African (D-SA), D-1873, and D-CB16. The toxins, except for those of C-CB19 and D-CB16, were purified, and antisera were prepared in rabbits. To clarify the antigenicity of the toxins, neutralization and agar gel double-diffusion tests were performed. Anti-C-ST toxin serum neutralized two kinds of type C(1) toxin to a similar extent. Antisera against D-SA and D-1873 toxins, however, showed different neutralizing activity toward three type D toxins. Precipitin lines formed between D-SA and D-1873 toxins, and their antisera spurred to each other. From anti-D-SA toxin serum, two neutralizing fractions, one which neutralized D-SA, D-1873, and D-CB16 and one which neutralized only D-SA, were obtained. These results indicate that the antigenicities of D-SA and D-1873 toxins are not identical. Anti-C-ST toxin serum produced cross-neutralization on type D toxins, although the neutralization titer differed depending on the kind of toxin used. A precipitin line was formed with D-SA toxin, but not with D-1873; the developed line spurred to the C-ST toxin precipitin line. Two anti-D toxin sera also caused cross-neutralization on type C(1) toxins. However, the neutralizing activity of each serum to the same type C(1) toxin was different, and only anti-D-SA toxin serum developed a precipitin line with C-ST toxin which spurred to the D-SA toxin precipitin line. From anti-D-SA toxin serum, two different fractions capable of neutralizing C(1) and D toxins were obtained; one neutralized C-ST, C-CB19, and D-SA toxins, but not D-1873 and D-CB16, and the other neutralized all five toxins. There may be at least two common parts among C-ST, C-CB16, and D-SA toxin molecules.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171518      PMCID: PMC350878          DOI: 10.1128/iai.34.2.382-388.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Hemagglutination by Clostridium botulinum type D.

Authors:  M STERNE
Journal:  Science       Date:  1954-04-02       Impact factor: 47.728

2.  Activation of a toxic component of Clostridium botulinum types C and D by trypsin.

Authors:  M W Eklund; F T Poysky
Journal:  Appl Microbiol       Date:  1972-07

3.  Bacteriophage and the toxigenicity of Clostridium botulinum type D.

Authors:  M W Eklund; F T Poysky; S M Reed
Journal:  Nat New Biol       Date:  1972-01-05

4.  Phage-conversion of toxigenicity in Clostridium botulinum types C and D.

Authors:  K Inoue; H Iida
Journal:  Jpn J Med Sci Biol       Date:  1971-02

5.  Conversion of toxigenicity in Clostridium botulinum type C.

Authors:  K Inoue; H Iida
Journal:  Jpn J Microbiol       Date:  1970-01

6.  Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.

Authors:  K Weber; J R Pringle; M Osborn
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

7.  The toxic antigenic factors produced by Clostridium botulinum types C and D.

Authors:  B C Jansen
Journal:  Onderstepoort J Vet Res       Date:  1971-06       Impact factor: 1.792

8.  Isolation and molecular size of Clostridium botulinum type C toxin.

Authors:  B Syuto; S Kubo
Journal:  Appl Environ Microbiol       Date:  1977-02       Impact factor: 4.792

9.  Antigenicity of converting phages obtained from Clostridium botulinum types C and D.

Authors:  K Oguma; H Iida; M Shiozaki; K Inoue
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

10.  Phage conversion to hemagglutinin production in Clostridium botulinum types C and D.

Authors:  K Oguma; H Iida; M Shiozaki
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

View more
  10 in total

1.  Molecular diversity of neurotoxins from Clostridium botulinum type D strains.

Authors:  K Moriishi; B Syuto; S Kubo; K Oguma
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Biochemical classification of Clostridium botulinum type C and D strains and their nontoxigenic derivatives.

Authors:  K Oguma; T Yamaguchi; K Sudou; N Yokosawa; Y Fujikawa
Journal:  Appl Environ Microbiol       Date:  1986-02       Impact factor: 4.792

3.  Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813.

Authors:  J Terajima; B Syuto; J O Ochanda; S Kubo
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

4.  Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.

Authors:  J O Ochanda; B Syuto; K Oguma; H Iida; S Kubo
Journal:  Appl Environ Microbiol       Date:  1984-06       Impact factor: 4.792

5.  Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies.

Authors:  K Oguma; S Murayama; B Syuto; H Iida; S Kubo
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

6.  Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum.

Authors:  K Oguma; T Agui; B Syuto; K Kimura; H Iida; S Kubo
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

Review 7.  Unique ganglioside binding by botulinum neurotoxins C and D-SA.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

Review 8.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

9.  Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum Type C and D neurotoxins.

Authors:  Hideyuki Arimitsu; Jae-Chul Lee; Yoshihiko Sakaguchi; Yuji Hayakawa; Michiko Hayashi; Miki Nakaura; Hikaru Takai; Song-Nan Lin; Masafumi Mukamoto; Tom Murphy; Keiji Oguma
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

10.  Confirmation of botulism diagnosis in Australian bird samples by ELISA and RT rtPCR.

Authors:  Anne M Masters; Dieter G Palmer
Journal:  J Vet Diagn Invest       Date:  2021-05-06       Impact factor: 1.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.